Press release
Inhaler Corticosteroid Device Market Outlook: Key Trends, Challenges, and Opportunities to 2031.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Inhaler Corticosteroid Device Market- (By Steroid Types (Beclomethasone Dipropionate, Budesonide, Fluticasone Inhaler Powder, & Mometasone), By Application (Asthma, COPD (Chronic Obstructive Pulmonary Disease) and Others) By End-user (Hospitals and Clinics, Academic and Research Institutes and Respiratory Care Center)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."According to the latest research by InsightAce Analytic, the Global Inhaler Corticosteroid Device Market is valued at US$ 616.09 Mn in 2023, and it is expected to reach US$ 886.4 Mn by 2031, with a CAGR of 4.6% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2441
Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in developing new inhaler corticosteroid devices. Hence, this factor is responsible for the growth of the inhaled corticosteroid device market. The inhaled corticosteroid device market refers to the market for devices used to administer inhaled corticosteroids (ICS). Inhaled corticosteroids are commonly prescribed medications for the long-term treatment of respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). These devices deliver the medication directly to the lungs, providing targeted and effective therapy. Inhaled corticosteroid devices are inhalation devices specifically designed to deliver corticosteroids to the respiratory system. These devices come in various forms, including metered-dose inhalers (MDIs), dry powder inhalers (DPIs), and nebulizers. They are commonly used by patients who require daily maintenance therapy to manage their respiratory conditions. The ever-increasing elderly population, growing awareness regarding pulmonary diseases, and rise in healthcare expenditure are sculpting growth in the market. Moreover, the rise in air pollution levels throughout the globe is fueling product demand.
List of Prominent Players in the Inhaler Corticosteroid Device Market:
• Pfizer Inc.
• GlaxoSmithKline plc
• Novartis AG
• Mylan N.V.
• Teva Pharmaceutical Industries Ltd.
• Sanofi
• Boehringer Ingelheim International GmbH.
• AstraZeneca
• F. Hoffmann-La Roche Ltd.
• Bristol-Myers Squibb Company
• Amgen Inc.
• Aurobindo Pharma
• Eli Lilly and Company
• Cipla Inc.
• Sumitomo Corporation
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The rising prevalence of asthma is a major factor driving the growth rate of the inhaled corticosteroids market. Asthma is a respiratory condition that affects the entire respiratory system, including the major, intermediate, and small airways. Respiratory tract irritation, as well as blockage, are caused due to asthma. Patients with asthma, especially those who are young or elderly, have a variety of therapy options. As a result, the inhaler device, which is simple to use, has piqued people's curiosity. The most often used asthma therapy tool is an inhaled corticosteroid. Another significant factor influencing the growth rate of the inhaled corticosteroids market is the rising healthcare expenditure, which helps in improving its infrastructure. Furthermore, rising initiatives by public and private organizations to spread awareness will expand the inhaled corticosteroids market. Additionally, high disposable income and rising addiction to smoking will result in the expansion of the inhaled corticosteroids market.
Challenges:
On the other hand, the expiration of patented drugs and the introduction of generic versions of drugs will obstruct the market's growth rate. The lack of healthcare infrastructure in developing economies and the high cost associated with inhaled corticosteroids will challenge the inhaled corticosteroids market. Additionally, side effects linked with inhaled corticosteroids, such as oral thrush, cough, hoarseness, sore throat, and others, will act as a restraint and further impede the market's growth rate. This pattern adds to cost-cognizant healthcare practices and impacts buying choices by healthcare suppliers and payers. Producers in the Inhaled Corticosteroids Device Market are progressively considering natural sustainability concerns. Endeavors are being made to foster inward breath devices with decreased natural effects, including eco-accommodating materials and charges.
Regional Trends:
North America emerges as the most dominant region in the inhaler corticosteroid device market share, holding a substantial share. This dominance is attributed to factors such as well-established healthcare infrastructure, a high prevalence of respiratory disorders, and a robust emphasis on technological advancements. The region's proactive approach to respiratory health, coupled with a significant patient population requiring long-term respiratory care, fuels the demand for inhaler corticosteroid devices. Additionally, continuous research and development activities, collaborations between industry players and research institutions, and favorable reimbursement policies contribute to the sustained growth of the inhaler corticosteroid device market in North America.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2441
Recent Developments:
• In September 2020, GlaxoSmithKline plc and Innoviva, Inc. announced the U.S. Food and Drug Administration (FDA) approval for a new indication of Trelegy Ellipta. It is also used to treat patients suffering from chronic obstructive pulmonary disease (COPD).
• BreatheSuite is a 2018 startup firm based in St.Johns, Canada. It has developed an integrated inhaler device for medication adherence to manage COPD and asthma.
• CareTRx is a mobile app and sensor offered by Gecko Health for the management of asthma. The device is added to pre-existing inhalers. It aims at assisting patients to better manage their asthma by tracking medication use.
Segmentation of Global Inhaler Corticosteroid Device Market-
Global Inhaler Corticosteroid Device Market- By Steroid Types
• Beclomethasone Dipropionate
• Budesonide
• Fluticasone Inhaler Powder
• Mometasone
Global Inhaler Corticosteroid Device Market- By Application
• Asthma
• COPD (Chronic Obstructive Pulmonary Disease)
• Others
Global Inhaler Corticosteroid Device Market- By End-User
• Hospitals and Clinics
• Academic and Research Institutes
• Respiratory Care Center
Global Inhaler Corticosteroid Device Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2441
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Inhaler Corticosteroid Device Market Outlook: Key Trends, Challenges, and Opportunities to 2031. here
News-ID: 3780388 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd

Biocides Market Latest Trends and Growth Factors Analysis 2024 to 2031
"Biocides Market" in terms of revenue was estimated to be worth $11.57 billion in 2023 and is poised to reach $16.83 billion by 2031, growing at a CAGR of 4.91% from 2024 to 2031, according to a new report by InsightAce Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1637
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Biocides Market are:
• Growing Awareness of Hygiene and…

Beneficial Insects Market Current Scenario with Future Trends Analysis to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Beneficial Insects Market Size, Share & Trends Analysis Report By Application (Crop protection, Crop production), Type (Predators, Parasitoids, Pathogens, and Pollinators), Crop Type (Fruits & Vegetables, Flowers & Ornamentals, and Grains & Pulses), Region, Market Outlook And Industry Analysis 2031"
The global Beneficial Insects market is estimated to reach over USD 2.18 billion by 2031, exhibiting…

Avocado Puree Market Current Scenario with Future Trends Analysis to 2031
The global avocado puree market is estimated to reach over USD 755.03 million by 2031, exhibiting a CAGR of 5.18% during the forecast period.
Fresh avocados mashed, puréed, pressed, or sieved into a creamy slurry or paste consistency are used to make avocado purees. Avocado purees make mixed fruit drinks, infant food, and guacamole. Avocado puree market revenue is predicted to increase at a high CAGR, driven by millennials' phenomenal demand…

Automotive Lead Acid Battery Market Latest Trends and Growth Factors Analysis 20 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Automotive Lead Acid Battery Market Size, Share & Trends Analysis Report By Product (SLI and Micro-Hybrid Batteries), Type (Flooded, Enhanced Flooded, and VRLA), Customer Segment (OEM and Aftermarket), End User (Passenger Car, Light Commercial Vehicles, Heavy Commercial Vehicles, Two-Wheeler, and Three-Wheeler), and Application (Hybrid Vehicles, Electric Vehicles, Light Motor Vehicles, and Heavy Motor Vehicles)- Market…
More Releases for Inhaler
Increasing Number Of Launches In Generic Version Of Budesonide Inhaler Drive The …
Budesonide is an artificial glucocorticoid steroid related to the naturally-occurring hormone, cortisol or hydrocortisone, which is produced in the adrenal glands. It is used for treating asthma. Budesonide is sold under the brand name Pulmicort. Each budesonide inhaler is designed to provide 60 to 120 inhalations depending on the device. Increasing air population is expected to lead to high prevalence of asthma worldwide. According to World Health Organization (WHO), asthma…
Global Digital Dose Inhaler Market Insights, Forecast
Digital Dose Inhaler is a kind of medical instrument. Digital Dose Inhaler enable patients to the number of tracking has consumed doses. The global Digital Dose Inhaler market is valued at 1790 million US$ in 2018 and will reach 3540 million US$ by the end of 2025, growing at a CAGR of 8.9% during 2019-2025. The objectives of this study are to define, segment, and project the size of the…
Global Inhaler Market Research and Forecast 2018-2023
“Inhalers- a faster and better way to deliver respiratory medication”
Orion Market Research (OMR) recently published a market research report on global inhaler market. It is forecasted that the market is augmenting with a significant CAGR during forecast period 2018-2023. The market is augmenting due to rising prevalence of respiratory disease, increasing air pollution and number of smokers. The global inhaler market is segmented by device, type, application and end-user. The…
Dry Powder Inhaler Market Report 2018: Segmentation by Product (Single Dose Dry …
Global Dry Powder Inhaler market research report provides company profile for Astrazeneca Plc., 3M Company, GlaxoSmithKline Plc, Novartis AG, Cipla Ltd., Teva Pharmaceutical Industries Limited, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., MannKind Corporation and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…
The Inhaler Devices has Driven The Market for Global Asthma Inhaler Device Marke …
Market Research Future published a Half - Cooked research report on “Global Asthma Inhaler Device Market Research Report- Forecast To 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.
Adherium limited, AstraZeneca, Boehringer Ingelheim GmbH, Chiesi Farmaceutici S.p.A., GSK plc, Propeller Health, and Teva Pharmaceutical Industries Ltd. and others are some of the prominent players at the forefront of competition in the Global Asthma Inhaler Devices Market and…
Asthma Inhaler Device Market by Metered Dose, Spacer and Dry Powder Type Inhaler …
The Worldwide Asthma Inhaler Device Market report provides various factors- price analysis, supply chain analysis, porters five force analysis etc. The report provides key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
Browse Complete 90 Pages Report enabled with Respective Tables and Figures is Available @ https://www.marketresearchfuture.com/reports/asthma-inhaler-device-market .
Asthma is a type of inflammatory disease of the lungs. It…